These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 11505447

  • 1. Lack of association between the kinetics of human cytomegalovirus (HCMV) glycoprotein B (gB)-specific and neutralizing serum antibodies and development or recovery from HCMV active infection in patients undergoing allogeneic stem cell transplant.
    Muñoz I, Gutiérrez A, Gimeno C, Farga A, Alberola J, Solano C, Prósper F, García-Conde J, Navarro D.
    J Med Virol; 2001 Sep; 65(1):77-84. PubMed ID: 11505447
    [Abstract] [Full Text] [Related]

  • 2. Cytomegalovirus-specific CD4 T-cell and glycoprotein B specific antibody response in recipients of allogenic stem cell transplantation.
    Ludwig B, Kraus FB, Kipp M, Preiser W, Schwerdtfeger R, Doerr HW, Buxbaum S.
    J Clin Virol; 2006 Feb; 35(2):160-6. PubMed ID: 16112610
    [Abstract] [Full Text] [Related]

  • 3. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
    Lilleri D, Fornara C, Chiesa A, Caldera D, Alessandrino EP, Gerna G.
    Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
    [Abstract] [Full Text] [Related]

  • 4. Use of recombinant glycoprotein antigens gB and gH for diagnosis of primary human cytomegalovirus infection during pregnancy.
    Eggers M, Radsak K, Enders G, Reschke M.
    J Med Virol; 2001 Feb; 63(2):135-42. PubMed ID: 11170050
    [Abstract] [Full Text] [Related]

  • 5. Little role of anti-gB antibodies in neutralizing activity of patient's sera with human cytomegalovirus (HCMV) infection.
    Park JW, Kim DJ, Kim J, Park CG, Hwang ES, Cha CY.
    J Korean Med Sci; 2000 Apr; 15(2):133-8. PubMed ID: 10803687
    [Abstract] [Full Text] [Related]

  • 6. Humoral immune response to functional regions of human cytomegalovirus glycoprotein B.
    Navarro D, Lennette E, Tugizov S, Pereira L.
    J Med Virol; 1997 Aug; 52(4):451-9. PubMed ID: 9260696
    [Abstract] [Full Text] [Related]

  • 7. Location, location, timing: analysis of cytomegalovirus epitopes for neutralizing antibodies.
    Schrader JW, McLean GR.
    Immunol Lett; 2007 Sep 15; 112(1):58-60. PubMed ID: 17714794
    [Abstract] [Full Text] [Related]

  • 8. HCMV gB genotype and its association with cytokine levels in hematopoietic stem cell transplantation.
    Correia-Silva JF, Resende RG, Arão TC, Abreu MH, Teixeira MM, Bittencourt H, Silva TA, Gomez RS.
    Oral Dis; 2011 Jul 15; 17(5):530-7. PubMed ID: 21332604
    [Abstract] [Full Text] [Related]

  • 9. Function of human cytomegalovirus glycoprotein B: syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies.
    Tugizov S, Navarro D, Paz P, Wang Y, Qadri I, Pereira L.
    Virology; 1994 Jun 15; 201(2):263-76. PubMed ID: 8184537
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.
    Hebart H, Rudolph T, Loeffler J, Middeldorp J, Ljubicic T, Jahn G, Einsele H.
    Bone Marrow Transplant; 2002 Aug 15; 30(3):181-7. PubMed ID: 12189537
    [Abstract] [Full Text] [Related]

  • 11. Early neutralizing and glycoprotein B (gB)-specific antibody responses to human cytomegalovirus (HCMV) in immunocompetent individuals with distinct clinical presentations of primary HCMV infection.
    Alberola J, Tamarit A, Igual R, Navarro D.
    J Clin Virol; 2000 Apr 15; 16(2):113-22. PubMed ID: 10720815
    [Abstract] [Full Text] [Related]

  • 12. Primary human cytomegalovirus infections: kinetics of ELISA-IgG and neutralizing antibody in pauci/asymptomatic pregnant women vs symptomatic non-pregnant subjects.
    Fornara C, Furione M, Lilleri D, Cane I, Revello MG, Zavattoni M, Gerna G.
    J Clin Virol; 2015 Mar 15; 64():45-51. PubMed ID: 25728078
    [Abstract] [Full Text] [Related]

  • 13. Lack of antibodies against the antigen domain 2 epitope of cytomegalovirus (CMV) glycoprotein B is associated with CMV disease after renal transplantation in recipients having the same glycoprotein H serotypes as their donors.
    Ishibashi K, Tokumoto T, Shirakawa H, Hashimoto K, Ikuta K, Kushida N, Yanagida T, Shishido K, Aikawa K, Toma H, Inoue N, Yamaguchi O, Tanabe K, Suzutani T.
    Transpl Infect Dis; 2011 Jun 15; 13(3):318-23. PubMed ID: 20804536
    [Abstract] [Full Text] [Related]

  • 14. Longitudinal analysis of human cytomegalovirus glycoprotein B (gB)-specific and neutralizing antibodies in AIDS patients either with or without cytomegalovirus end-organ disease.
    Alberola J, Tamarit A, Cardeñoso L, Estellés F, Igual R, Navarro D.
    J Med Virol; 2001 May 15; 64(1):35-41. PubMed ID: 11285566
    [Abstract] [Full Text] [Related]

  • 15. Serum antibody response to the gH/gL/pUL128-131 five-protein complex of human cytomegalovirus (HCMV) in primary and reactivated HCMV infections.
    Genini E, Percivalle E, Sarasini A, Revello MG, Baldanti F, Gerna G.
    J Clin Virol; 2011 Oct 15; 52(2):113-8. PubMed ID: 21820353
    [Abstract] [Full Text] [Related]

  • 16. Effect of serum and CTL on focal growth of human cytomegalovirus.
    Sinzger C, Mangin M, Weinstock C, Topp MS, Hebart H, Einsele H, Jahn G.
    J Clin Virol; 2007 Feb 15; 38(2):112-9. PubMed ID: 17204454
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of human cytomegalovirus (HCMV) gB genotypes in Thai patients.
    Bhattarakosol P, Chantaraarphonkun S.
    Southeast Asian J Trop Med Public Health; 2007 Sep 15; 38(5):835-40. PubMed ID: 18041299
    [Abstract] [Full Text] [Related]

  • 18. Human cytomegalovirus-specific T cell reconstitution in young patients receiving T cell-depleted, allogeneic hematopoietic stem cell transplantation.
    Lilleri D, Gerna G, Fornara C, Chiesa A, Comolli G, Zecca M, Locatelli F.
    J Infect Dis; 2009 Mar 15; 199(6):829-36. PubMed ID: 19239337
    [Abstract] [Full Text] [Related]

  • 19. Antibody response to human cytomegalovirus (HCMV) glycoprotein B (gB) in AIDS patients with HCMV end-organ disease.
    Alberola J, Domínguez V, Cardeñoso L, López-Aldeguer J, Blanes M, Estellés F, Ricart C, Pastor A, Igual R, Navarro D.
    J Med Virol; 1998 Aug 15; 55(4):272-80. PubMed ID: 9661835
    [Abstract] [Full Text] [Related]

  • 20. Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H.
    Elkington R, Shoukry NH, Walker S, Crough T, Fazou C, Kaur A, Walker CM, Khanna R.
    Eur J Immunol; 2004 Nov 15; 34(11):3216-26. PubMed ID: 15368271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.